Epigenetic basis of diabetic vasculopathy
Related Experiment Video
Updated: Aug 16, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Theja Bhamidipati1, Manishekhar Kumar2, Sumit S Verma2
1Department of Vascular Surgery, Jefferson-Einstein Medical Center, Philadelphia, PA, United States.
Abstract:
Type 2 diabetes mellitus (T2DM) causes peripheral vascular disease because of which several blood-borne factors, including vital nutrients fail to reach the affected tissue. Tissue epigenome is sensitive to chronic hyperglycemia and is known to cause pathogenesis of micro- and macrovascular complications. These vascular complications of T2DM may perpetuate the onset of organ dysfunction. The burden of diabetes is primarily because of a wide range of complications of which nonhealing diabetic ulcers represent a major component. Thus, it is imperative that current research help recognize more effective methods for the diagnosis and management of early vascular injuries. This review addresses the significance of epigenetic processes such as DNA methylation and histone modifications in the evolution of macrovascular and microvascular complications of T2DM.
Insights
Type 2 diabetes mellitus (T2DM) leads to vascular issues, impacting nutrient delivery and causing organ dysfunction. Epigenetic changes like DNA methylation and histone modifications are key drivers of these T2DM-related vascular complications.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Genetics
Background:
- Type 2 diabetes mellitus (T2DM) is linked to peripheral vascular disease, hindering nutrient transport to tissues.
- Chronic hyperglycemia in T2DM affects the tissue epigenome, contributing to micro- and macrovascular complications.
- These vascular issues can accelerate organ dysfunction and lead to complications like nonhealing diabetic ulcers.
Purpose of the Study:
- To review the role of epigenetic modifications in the development of vascular complications in T2DM.
- To highlight the importance of understanding epigenetics for improved diagnosis and management of early vascular injuries in diabetes.
Main Methods:
- Literature review focusing on epigenetic mechanisms in T2DM vascular complications.
- Analysis of studies investigating DNA methylation and histone modifications in relation to T2DM pathogenesis.
Main Results:
- Epigenetic processes, including DNA methylation and histone modifications, are significantly involved in the pathogenesis of both microvascular and macrovascular complications of T2DM.
- These epigenetic alterations can explain how chronic hyperglycemia impacts vascular health and contributes to disease progression.
Conclusions:
- Epigenetic modifications are crucial in the development of vascular complications associated with Type 2 diabetes mellitus.
- Further research into these epigenetic mechanisms is essential for developing novel diagnostic and therapeutic strategies for T2DM vascular disease.
More Related Videos
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Regulation of Angiogenesis and Blood Supply
Insulin Secretory Vesicles
Psychoneuroimmunology: Diabetes and Cancer